CDC expected to give final approval on new COVID-19 vaccine
The FDA gave its approval for the updated vaccines from Moderna and Pfizer on Monday.
Watch CBS News
The FDA gave its approval for the updated vaccines from Moderna and Pfizer on Monday.
The vaccine for pregnant women would be given between 32 and 36 weeks of pregnancy and would protect newborns for six months.
A maternal RSV vaccine could be a big benefit to families and ERs, doctors say.
Pfizer’s experimental RSV vaccine would be given in late pregnancy so mothers can pass antibodies onto their babies to protect against the virus.
Pfizer working to combine both vaccines into one shot.
The panel will next vote on rival Moderna's version of the booster update, to be used in adults only
The BA.5 variant is responsible for almost all of the new covid-19 infections in the United States.
A local pediatrician spoke with Eyewitness News on Tuesday night about what she wants to see before the approval is given.
If cleared by the FDA, 19 million children under the age of 5 will have access to a COVID vaccine.
Health officials welcome boosters going into the holiday season since there's been a 35% spike nationwide in new cases in recent weeks and hospitalizations up 6%.
Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.
A CBS News poll showed only about a third of parents -- 37% -- will get their kids vaccinated if it's authorized; 26% say maybe; and 35% will not.
Coren says while some parents are jumping on the opportunity right away, others are hesitant.
The dose for young children is just one-third of the Pfizer shot already recommended for everyone 12 and older.
In a new document posted ahead of a key meeting of the US Food and Drug Administration's vaccine advisers, Pfizer says its vaccine is safe and 90.7% effective against symptomatic COVID-19 in children ages 5 to 11.
Pfizer and BioNTech said Thursday they are seeking U.S. Food and Drug Administration emergency use authorization for their COVID-19 vaccine for children ages 5 to 11.
President Joe Biden wanted boosters to be available for everyone this week. That's not happening.
The FDA's decision to reject Pfizer's booster shot request for the majority of Americans may have surprised some, but one local nurse says he expected it.
The big issue right now is the delta variant and increasing infection rates mainly among people who aren't vaccinated.
Expanded authorization of the Pfizer vaccine means 85% of the U.S. population would be eligible to receive a COVID-19 vaccine.
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday.
Clinical trial results of Pfizer/BioNTech's COVID-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday.
The error could mean more than 100,000 people will need appointments rescheduled, state health officials said Wednesday.
Pennsylvania is reporting more than 9,600 new cases of COVID-19 Wednesday.
The first batches of the Pfizer COVID-19 vaccine began arriving in Philadelphia and other locations around the region Monday.
